Discussion
Loading...

Post

  • About
  • Code of conduct
  • Privacy
  • Users
  • Instances
  • About Bonfire
Conny with a Y :tinoflag:
@ConnyChiwa@mastodon.nz  ·  activity timestamp 2 weeks ago

German study shows promising results in infection reduction (not just for Covid but also for other respiratory viruses) using a hayfever nasal spray:
A two-thirds reduction in the risk of infection in the clinical study with 450 healthy adults, the active ingredient azelastine, which is contained in Ursapharm's hay fever spray Pollival®, was tested. "Our results show that the 227 participants who regularly used the azelastine nasal spray had a reduced risk of contracting corona infection by about two-thirds compared to the 223 participants who were treated with a placebo alone," says Professor Dr. Dr. Robert Bals.
https://www.eurekalert.org/news-releases/1096684
Article in German:
https://www.saarbruecker-zeitung.de/saarland/saarland-heuschnupfenspray-schuetzt-gegen-corona-und-das-ist-noch-nicht-alles_aid-134126961

An equivalent product is available in Aotearoa:
https://www.dymista.co.nz/en-nz/product/dymista
https://www.medsafe.govt.nz/Consumers/cmi/d/dymista.pdf
Dymista has 125mcg of active ingredient vs 140mcg in the German product. Apparently, it's most effective at 5 doses/day.

The best deal I've found is $38/17ml bottle at:
https://www.pharmacydirect.co.nz/Dymista-Nasal-Spray-120-Dose

#CovidNZ
#CovidIsNotOver
#TeamVorsicht

  • Copy link
  • Flag this post
  • Block
Log in

bonfire.cafe

A space for Bonfire maintainers and contributors to communicate

bonfire.cafe: About · Code of conduct · Privacy · Users · Instances
Bonfire social · 1.0.0-rc.2.21 no JS en
Automatic federation enabled
  • Explore
  • About
  • Members
  • Code of Conduct
Home
Login